Recent Quarter Total Invested
$59.76 M
Recent Quarter Institutional Ownership Percentage
74.34%
Total Invested of Last Quarter
$69.70 M
Ownership Percentage of Last Quarter
76.81%
Aclaris Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 08/07/2024 | 12.99 M | $14.29 M | 38.23% | 18.27% |
| VANGUARD GROUP INC | 08/13/2024 | 4.69 M | $5.16 M | -4.91% | 6.60% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 3.34 M | $3.67 M | 1.94% | 4.69% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 3.32 M | $3.65 M | 1.13% | 4.67% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 2.75 M | $3.03 M | 0.00% | 3.87% |
| BLACKROCK INC. | 08/13/2024 | 2.03 M | $2.24 M | -60.94% | 2.86% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/21/2024 | 1.93 M | $2.12 M | 100.00% | 2.71% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 1.91 M | $2.10 M | -10.39% | 2.69% |
| TRIUM CAPITAL LLP | 08/06/2024 | 1.89 M | $2.08 M | 100.00% | 2.66% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 1.44 M | $1.58 M | -0.98% | 2.02% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 1.11 M | $1.22 M | -16.29% | 1.57% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/12/2024 | 1.00 M | $1.10 M | -66.67% | 1.41% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 940,752 | $1.03 M | -22.40% | 1.32% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 923,313 | $1.02 M | -3.52% | 1.30% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 922,200 | $1.01 M | -44.89% | 1.30% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 916,620 | $1.01 M | 528.63% | 1.29% |
| CITADEL ADVISORS LLC | 08/14/2024 | 875,216 | $962,738 | -5.89% | 1.23% |
| ALDEBARAN CAPITAL, LLC | 08/13/2024 | 858,152 | $943,967 | 100.00% | 1.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 774,137 | $851,714 | -50.54% | 1.09% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2024 | 696,171 | $765,788 | 0.00% | 0.98% |
| FMR LLC | 08/13/2024 | 689,353 | $758,288 | 2.61% | 0.97% |
| PALO ALTO INVESTORS LP | 08/14/2024 | 569,832 | $626,815 | 0.00% | 0.80% |
| NORTHERN TRUST CORP | 08/14/2024 | 520,469 | $572,516 | -7.43% | 0.73% |
| ACUITAS INVESTMENTS, LLC | 08/05/2024 | 464,120 | $510,532 | 0.53% | 0.65% |
| AISLING CAPITAL MANAGEMENT LP | 08/08/2024 | 434,455 | $477,901 | 0.00% | 0.61% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 386,177 | $424,795 | -36.92% | 0.54% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 336,677 | $370,000 | -50.43% | 0.47% |
| JANE STREET GROUP, LLC | 08/15/2024 | 335,009 | $368,510 | 0.99% | 0.47% |
| HIGHTOWER ADVISORS, LLC | 08/13/2024 | 312,714 | $344,000 | 0.03% | 0.44% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 264,377 | $290,815 | 0.00% | 0.37% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 260,706 | $286,777 | -37.83% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 206,600 | $227,260 | 67.34% | 0.29% |
| STATE STREET CORP | 08/14/2024 | 196,621 | $216,283 | -85.31% | 0.28% |
| MORGAN STANLEY | 08/14/2024 | 186,343 | $204,977 | -62.10% | 0.26% |
| ALPINE GLOBAL MANAGEMENT, LLC | 08/14/2024 | 177,909 | $195,700 | 100.00% | 0.25% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 150,700 | $165,770 | 100.00% | 0.21% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 139,400 | $154,000 | 27.00% | 0.20% |
| MAN GROUP PLC | 08/14/2024 | 118,459 | $130,305 | -52.17% | 0.17% |
| CENTIVA CAPITAL, LP | 08/14/2024 | 117,966 | $129,763 | 100.00% | 0.17% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/09/2024 | 115,580 | $127,138 | 14.69% | 0.16% |
| Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 114,806 | $126,287 | 100.00% | 0.16% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 09/16/2024 | 107,929 | $118,722 | 100.00% | 0.15% |
| SQUAREPOINT OPS LLC | 08/14/2024 | 94,687 | $104,156 | 100.00% | 0.13% |
| MARQUETTE ASSET MANAGEMENT, LLC | 08/14/2024 | 83,979 | $92,377 | 0.00% | 0.12% |
| VERITION FUND MANAGEMENT LLC | 08/14/2024 | 82,883 | $91,171 | 53.96% | 0.12% |
| HRT FINANCIAL LP | 08/12/2024 | 81,005 | $89,000 | 100.00% | 0.11% |
| PALOMA PARTNERS MANAGEMENT CO | 08/14/2024 | 79,200 | $87,120 | 100.00% | 0.11% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 76,759 | $84,435 | -13.81% | 0.11% |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 07/30/2024 | 72,091 | $79,300 | -9.88% | 0.10% |
| ENGINEERS GATE MANAGER LP | 08/14/2024 | 60,536 | $66,590 | 5.95% | 0.09% |
Aclaris Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ACRS shares?
During the previous two years, 143 institutional investors and hedge funds held shares of Aclaris Therapeutics, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 12.99 M
VANGUARD GROUP INC: 4.69 M
MILLENNIUM MANAGEMENT LLC: 3.34 M
D. E. Shaw & Co., Inc.: 3.32 M
Rock Springs Capital Management LP: 2.75 M
BlackRock Inc.: 2.03 M
-
What percentage of Aclaris Therapeutics, Inc. stock is owned by institutional investors?
74.34% of Aclaris Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ACRS ?
Institutional investors have bought a total of 57.93 M shares in the last 24 months. This purchase volume represents approximately $68.94 M in transactions.